EIDD-2801

98%

  • Product Code: 65309
  CAS:    2349386-89-4
Molecular Weight: 329.31 g./mol Molecular Formula: C₁₃H₁₉N₃O₇
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: EIDD-2801 has shown significant potential in antiviral applications, particularly in the treatment of RNA virus infections. It has been studied extensively for its efficacy against SARS-CoV-2, the virus responsible for COVID-19, where it acts as a broad-spectrum antiviral by introducing errors into the viral RNA during replication, thereby inhibiting its ability to spread. Beyond COVID-19, it has demonstrated activity against other RNA viruses such as influenza, Ebola, and respiratory syncytial virus (RSV), making it a promising candidate for addressing future viral outbreaks. Its oral bioavailability allows for convenient administration, which is advantageous in both clinical and outpatient settings. Research is ongoing to explore its potential in treating other viral infections and its role in combination therapies to enhance antiviral effects.
Product Specification:
Test Specification
APPEARANCE Almost white crystalline powder
PURITY 97.5-100
WATER 1.0
Infrared spectrum Conforms to Structure
NMR Conforms to Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days €8.44
+
-
0.010 10-20 days €10.82
+
-
0.050 10-20 days €18.20
+
-
0.250 10-20 days €36.67
+
-
EIDD-2801
EIDD-2801 has shown significant potential in antiviral applications, particularly in the treatment of RNA virus infections. It has been studied extensively for its efficacy against SARS-CoV-2, the virus responsible for COVID-19, where it acts as a broad-spectrum antiviral by introducing errors into the viral RNA during replication, thereby inhibiting its ability to spread. Beyond COVID-19, it has demonstrated activity against other RNA viruses such as influenza, Ebola, and respiratory syncytial virus (RSV), making it a promising candidate for addressing future viral outbreaks. Its oral bioavailability allows for convenient administration, which is advantageous in both clinical and outpatient settings. Research is ongoing to explore its potential in treating other viral infections and its role in combination therapies to enhance antiviral effects.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: €0.00
€0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page